FIMM

Organiser: FIMM in collaboration with Health Capital Helsinki

The Institute for Molecular Medicine Finland (FIMM) has close connections to the HUS Helsinki University Hospital and extensive experience with patient sample deep molecular profiling and machine-assisted analysis. In this webinar, FIMM presents how they’ve have been able to attract, maintain and increase collaborations with several clinical stage pharmaceutical partners.

Speak­ers:
Research Director Caroline Heckman (FIMM), Professor Kimmo Porkka (HUS), and Executive Director, Oncology Precision Medicine Celine Pallaud (Novartis)